Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice-Reference-Cited by-同舟云学术

Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice

Published:2009-12-23 Issue:5 Volume:51 Page:1702-1711
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Beldi Guido,Banz Yara,Kroemer Alexander,Sun Xiaofeng,Wu Yan,Graubardt Nadine,Rellstab Alyssa,Nowak Martina,Enjyoji Keiichi,Li Xian,Junger Wolfgang G.,Candinas Daniel,Robson Simon C.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23510/fullpdf

Reference32 articles.

1. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation;Lappas;J Exp Med,2006

2. The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney;Feng;Transplant Proc,2006

3. Promotion of hepatic ischemia/reperfusion injury by IL-12 is independent of STAT4;Kato;Transplantation,2002

4. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice;Takeuchi;HEPATOLOGY,2004

5. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy;Friedman;Diabetes,2007

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innate immunity and early liver inflammation;Frontiers in Immunology;2023-05-02

2. Emerging roles of purinergic signaling in anti-cancer therapy resistance;Frontiers in Cell and Developmental Biology;2022-09-19

3. Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers;Frontiers in Immunology;2022-06-27

4. Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue;International Immunopharmacology;2021-11

5. Chitosan Nanovaccines as Efficient Carrier Adjuvant System for IL-12 with Enhanced Protection Against HBV;International Journal of Nanomedicine;2021-07